DoD Reconstructive Transplant, Investigator Initiated Research Award

0
2

Funding Opportunity ID:335127
Opportunity Number:W81XWH-21-RTRP-IIRA
Opportunity Title:DoD Reconstructive Transplant, Investigator Initiated Research Award
Opportunity Category:Discretionary
Opportunity Category Explanation:
Funding Instrument Type:Cooperative Agreement
Grant
Category of Funding Activity:Science and Technology and other Research and Development
Category Explanation:
CFDA Number(s):12.420
Eligible Applicants:Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:
Agency Code:DOD-AMRAA
Agency Name:Department of Defense
Dept. of the Army — USAMRAA
Posted Date:Aug 04, 2021
Close Date:Dec 08, 2021
Last Updated Date:Aug 04, 2021
Award Ceiling:$0
Award Floor:$0
Estimated Total Program Funding:$12,000,000
Expected Number of Awards:7
Description:The FY21 RTRP Investigator-Initiated Research Award is intended to support studies that have the potential to make an important contribution to reconstructive transplant research, patient care, and/or quality of life. Though the RTRP Investigator-Initiated Research Award mechanism supports groundbreaking research, all projects must demonstrate solid scientific rationale with military-relevant utility. Important aspects of this award mechanism include: • Study Design and Feasibility: The proposed study design should be clearly described, rigorous, and support maximal reproducibility and translational feasibility. A statistical plan with appropriate power analysis should be included, as applicable. • Impact: The short- and long-term impact of the proposed research should be clearly articulated. Projects must address at least one of the FY21 RTRP Investigator-Initiated Research Award Focus Areas. • Military Relevance: All projects should be responsive to the healthcare needs of military Service Members and/or Veterans recovering from traumatic injury, and/or their family members, caregivers or clinicians, as well as the general public. Collaboration with military researchers and clinicians is encouraged, but not required. • Preliminary Data: Observations that drive a research idea may be derived from laboratory discovery, population-based studies, a clinician’s first-hand knowledge of patients, or anecdotal data. Preliminary and/or published data that are relevant to reconstructive transplantation and that support the rationale for the proposed research must be included for applications submitted under any Investigator-Initiated Research Award Focus Area other than the “Retrospective studies of VCA” Focus Area. Investigator-Initiated Research Award applications may focus on any phase of research from basic through translational, including preclinical studies in animal models, human subjects, human anatomical substances, as well as correlative studies associated with an existing clinical trial. Clinical trials are not allowed under this funding opportunity. A clinical trial is defined as a research study in which one or more human subjects are prospectively assigned to one or more interventions (which may include placebo or other control) to evaluate the effects of the interventions on biomedical or behavioral health-related outcomes.
Version:1





Visit the Official Webpage For More Details on DoD Reconstructive Transplant, Investigator Initiated Research Award

LEAVE A REPLY

Please enter your comment!
Please enter your name here